Low-dose aspirin to reduce recurrence rate in colorectal cancer patients with PI3K pathway alterations: 3-year results from a randomized placebo-controlled trial.

被引:0
|
作者
Martling, Anna
Lindberg, Johan
Myrberg, Ida Hed
Nilbert, Mef
Mayrhofer, Markus
Gronberg, Henrik
Glimelius, Bengt
ALASCCA Trial Study Grp
机构
[1] Karolinska Inst, Stockholm, Sweden
[2] Lund Univ, Lund, Sweden
[3] Akadem Univ Hosp, Uppsala, Sweden
基金
瑞典研究理事会;
关键词
D O I
10.1200/JCO.2025.43.4_suppl.LBA125
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:LBA125 / LBA125
页数:1
相关论文
共 50 条
  • [41] The effect of hormone replacement therapy, alendronate, or the combination of both on hip structural geometry: A 3-year, randomized, double-blind, placebo-controlled, NIH-funded clinical trial.
    Greenspan, SL
    Bhattacharya, R
    Beck, TJ
    Resnick, NM
    Parker, RA
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S92 - S92
  • [42] FINAL 5-YEAR SAFETY AND EFFICACY RESULTS OF A PHASE 3, RANDOMIZED PLACEBO-CONTROLLED TRIAL OF GOLIMUMAB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE
    Keystone, Edward
    Genovese, Mark C.
    Hall, Stephen
    Miranda, Pedro C.
    Bae, Sang-Cheol
    Han, Chenglong
    Gathany, Tim
    Zhou, Yiying
    Xu, Stephen
    Hsia, Elizabeth C.
    RHEUMATOLOGY, 2014, 53 : 99 - 99
  • [43] Effect of omega 3 fatty acids plus low-dose aspirin on both clinical and biochemical profiles of patients with chronic periodontitis and type 2 diabetes: a randomized double blind placebo-controlled study
    Elwakeel, N. M.
    Hazaa, H. H.
    JOURNAL OF PERIODONTAL RESEARCH, 2015, 50 (06) : 721 - 729
  • [44] PI3K/AKT pathway gene and miRNA alterations in triple-negative breast cancer patients from Latin America.
    de Oliveira, Marcia M.
    Sugita, Bruna
    Pereira, Silma R.
    Lima, Rubens S.
    Urban, Cicero A.
    Ribeiro, Enilze M. S. F.
    Cavalli, Iglenir J.
    Cavalli, Luciane R.
    CLINICAL CANCER RESEARCH, 2018, 24 (01) : 35 - 35
  • [45] The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2x2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients
    Petrera, Marilena
    Paleari, Laura
    Clavarezza, Matteo
    Puntoni, Matteo
    Caviglia, Silvia
    Briata, Irene Maria
    Oppezzi, Massimo
    Mislej, Eva Mihajlovic
    Stabuc, Borut
    Gnant, Michael
    Bachleitner-Hofmann, Thomas
    Roth, Wilfried
    Scherer, Dominique
    Haefeli, Walter-E.
    Ulrich, Cornelia M.
    DeCensi, Andrea
    BMC CANCER, 2018, 18
  • [46] Effectiveness of long-term low-dose aspirin in the prevention of gastric cancer after Helicobacter pylori eradication: study design and rationale of Ardabil gastric cancer randomized placebo-controlled prevention trial (AGCPT)
    Pourfarzi, Farhad
    Rashidi, Mohammad-Mahdi
    Yazdanbod, Abbas
    Nemati, Ali
    Dogaheh, Hadi Peeri
    Faghfuri, Elnaz
    Gorgani, Fateme
    Hosseini-Asl, Saied
    Zamani, Bijan
    Pourfarzi, Sanaz
    Etemadi, Arash
    Shafighian, Fateme
    Rezaei, Negar
    Poustchi, Hossein
    Malekzadeh, Reza
    Sadjadi, Alireza
    TRIALS, 2024, 25 (01)
  • [47] Low-dose Infliximab (3 mg/kg) Significantly Reduces Spinal Inflammation on Magnetic Resonance Imaging in Patients with Ankylosing Spondylitis: A Randomized Placebo-controlled Study
    Maksymowych, Walter P.
    Salonen, David
    Inman, Robert D.
    Rahman, Proton
    Lambert, Robert G. W.
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (08) : 1728 - 1734
  • [48] Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial
    Schindler, Emmanuelle A. D.
    Sewell, R. Andrew
    Gottschalk, Christopher H.
    Luddy, Christina
    Flynn, L. Taylor
    Zhu, Yutong
    Lindsey, Hayley
    Pittman, Brian P.
    Cozzi, Nicholas V.
    D'Souza, Deepak C.
    HEADACHE, 2022, 62 (10): : 1383 - 1394
  • [49] PREDICTORS OF RESPONSE TO CORTICOSTEROID THERAPY IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF BUDESONIDE ORAL SUSPENSION
    Hirano, Ikuo
    Katzka, David A.
    Collins, Margaret H.
    Mukkada, Vincent A.
    Gold, Benjamin D.
    Falk, Gary W.
    Williams, James
    Desai, Nirav K.
    Lan, Lan
    Dellon, Evan S.
    GASTROENTEROLOGY, 2020, 158 (06) : S817 - S818
  • [50] Improved Histopathologic Features in Patients With Eosinophilic Esophagitis: Results and Analyses From a Phase 3, Randomized, Placebo-Controlled Trial of Budesonide Oral Suspension
    Collins, Margaret H.
    Hirano, Ikuo
    Katzka, David A.
    Mukkada, Vincent A.
    Falk, Gary W.
    Williams, James E.
    Desai, Nirav K.
    Lan, Lan
    Dellon, Evan S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S200 - S201